Sub menu

 

 

FOI disclosure log

The Freedom of Information (FOI) disclosure log shows information which has been released in response to FOI requests.

Last updated

About the Freedom of Information (FOI) disclosure log

The Department of Health and Aged Care, of which the TGA is a part, is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to disclose access decisions through a disclosure log on its website. The disclosure log provides access to information which has been released in response to an FOI request. However, personal information and information about the business, commercial, financial or professional affairs of a person is deleted from the documents if publication of that information would be unreasonable.

The documents released by the TGA under section 11C of the FOI Act have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Coordinator by emailing tga.foi@health.gov.au or calling the TGA on 1800 020 653 or 02 6289 4630.

For information on what’s involved when you request information from us and what's covered under the FOI Act, go to Freedom of information.

For documents released under the FOI Act by the Australian Government Department of Health and Aged Care, please visit the Department of Health's FOI disclosure log.

Our Freedom of Information (FOI) disclosure log

Date of releaseFOI numberDocuments
4 December 202526-1972

Correspondence between Novavax/Biocelect and the TGA concerning registration of Nuvaxovoid in the Australian Register of Therapeutic Goods.

1 December 202526-2376

Data relating to Schedule 3 Special Access Scheme (SAS C) pharmacist notifications to TGA of supply of vaping products from 1 October 2024 to 31 October 2025.

28 November 202526-2095

Notifications submitted to the TGA by Sandoz Pty Ltd regarding the shortages of Estradot 100 patches (AUST R: 338060).

26 November 202526-2150

Special Access Scheme and Authorised Prescriber data for Sodium Thiosulfate (Thiosulphate) for the period 1 January 2025 to 30 June 2025.

26 November 202526-2338

Complaints or correspondence mentioning ChatGPT from November 2022 to 23 October 2025.

24 November 202526-2139

GMP inspection of manufacturing site for GMP Pharmaceuticals

17 November 202526-2254

Unredacted copies of 25-0162 documents.

14 November 202526-2078

Report listing overseas medicine manufacturing sites located in the People’s Republic of China that have been included in an active TGA GMP clearance for sterile injectable (parenteral) vials/bags, covering the manufacture of human medicines.

4 November 202526-2296

Non-cannabis liquid medicines accessed under the Special Access Scheme.

31 October 202526-2256

Data relating to the supply of vaping products via the Special Access Scheme Category C from 1 October 2024 to 30 September 2025.

31 October 202526-2274

Data relating to Special Access Scheme and Authorised Prescriber approvals for Levosimendan for infusion for the period 1 January 2024 to 31 July 2025.

22 October 202526-2239

Data relating to Special Access Scheme applications for Metyrapone, Ketoconazole, Tocilizumab, Rituximab and Unituxin for the period 2018 to 29 September 2025.

14 October 202526-1958

Documents relating to Iverjohn-12 and Ivervid-12 branded tablets.

13 October 202526-1870

Liber Pharmaceuticals involvement in 2024 vaping reforms.

7 October 202526-1990

Approved carton and vial label artwork for Vidaza Powder for Injection, 100 mg.

5 October 202526-2278

Data on the number of units of unregistered medicinal cannabis products supplied for the period 1 January 2025 to 30 June 2025.

30 September 202526-2142

Data on the number of units of unregistered medicinal cannabis products supplied for the period 1 January 2025 to 30 June 2025.

30 September 202526-2122

Minutes of the 161st meeting of the Pharmaceutical Sub Committee of the Advisory Committee on Prescription Medicines on 24th March 2015 regarding the matter of preservatives in single use injections.

30 September 202526-1879

Copies of earliest iteration of product packaging for various over-the-counter medications.

29 September 202526-2100

Data relating to Schedule 3 Special Access Scheme (SAS C) pharmacist notifications to TGA of supply of vaping products from 1 October 2024 to 31 August 2025.

29 September 202526-2102

Data relating to medicinal cannabis SAS-B applications for the period November 2021 to 31 July 2025.

29 September 202526-1874

Copies of earliest iteration of product packaging for various over-the-counter medications.

25 September 202525-0220

Minutes of meetings where adverse event reporting rates are discussed in relation to Covid-19 vaccines.

25 September 202525-0158

TGA signal notification assessments, signal investigation and signal evaluation documents for the potential safety signals of COVID-19 vaccines for menstrual cycle irregularities/disorders.

23 September 202525-0216

Documents relating to the Complementary and OTC Medicines Regulatory & Technical Forum (ComTech).

11 September 202525-0214

Device Incident Reports (DIR) and documents relating to Stryker Hip Stem (ARTG 145594) and Acetabular Shell (ARTG 152396).

9 September 202525-0197

Carton design, label design, product information and consumer medicine information relating to Depo-Provera (ARTG 12300, 12279 and 401610); and Depo‐Ralovera (ARTG 44464). 

8 September 202526-1867

ARTG Certificates and Registration entries for Nitrostat (AUST R 438851 and 438870) and Anginine (AUST R 11086 and 227783).

1 September 202526-1963

Adverse event data for COVID-19 vaccines from 21 December 2020 to 31 July 2025. 

29 August 202526-1936

Laboratory reports for Iverheal-12 

29 August 202526-1978

Schedule 3 Special Access Scheme (SAS C) pharmacist notifications to TGA of supply of vaping products from 1 October 2024 to 31 July 2025.

27 August 202526-1889

Documents relating to the cancellation of Bioglan Astragalus (ARTG ID 289150 from the Australian Register of Therapeutic Goods.

26 August 202525-0211

GMP Inspection reports for GMP Pharmaceuticals Pty Ltd as the licensed manufacturer. 

21 August 202525-0232

TGA assessment report related to evaluation of ZO-RUB HP capsaicin 0.075% w/w cream tube (AUST R 198783).

18 August 202525-0223

Documentation relating to adverse reactions or potential adverse reactions for therapeutic sunscreens under the brand name Ultra Violette.

15 August 202525-0206

Documents relating to ARTG 295158 - Intense pulsed light skin surface treatment system.

15 August 202525-0217

Correspondence relating to the processing of FOI 25-0171 between the FOI requester and the TGA.

7 August 202526-1890

Adverse event notifications made to the TGA, and associated correspondence, for all unapproved medicinal cannabis products.

6 August 202525-0199

Documents related to internal audits conducted by the TGA’s Pharmaceutical Inspectorate.

1 August 202525-0204

Request for application, including any form of supporting documentation for ARTG 488139 – Dr Nature Immunity & Lung Tablet.

30 July 202526-1888

Special Access Scheme data for Cefiderocol for the period 1 January 2020 to 30 June 2025.

28 July 20252565

Toxicity studies of COVID-19 vaccines.

24 July 202525-0233

Special Access Scheme and Authorised Prescriber data for MDMA/psilocybin for the period 1 July 2023 to 30 June 2025.

24 July 202526-1861

Special Access Scheme (SAS) notifications of vaping supply from 1 October 2024 to 30 June 2025.

22 July 202525-0165

Documents relating to the reintroduction of Zantac in the Australian market.

21 July 202525-0040

Documents relating to menstrual problems following COVID-19 vaccination.

14 July 202525-0222

Spreadsheet containing time-to-death (TTD) data, attenuated to include only the TTD data for adverse event reports where the only coded MedDRA term is ‘adverse event following immunisation’.

14 July 20252255

Documents relating to Covid-19 otherwise known as Coronavirus Disease 2019 and SARS-CoV-2.

7 July 202525-0417

Documents relating to Boston Scientific Pty Ltd pacemakers.

1 July 2024 to 30 June 2025Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2024 - Jun 2025
1 Jul 2023 to 30 Jun 2024Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2023 - Jun 2024
1 Jul 2022 to 30 Jun 2023Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2022 to Jun 2023
1 Jul 2021 to 30 Jun 2022Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2021 to Jun 2022
1 Jul 2020 to 30 Jun 2021Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2020 to Jun 2021
1 Jul 2019 to 30 Jun 2020Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2019 to Jun 2020
1 Jul 2018 to 30 Jun 2019Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 to Jun 2019
1 Jul 2017 to 30 Jun 2018Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018
1 Jul 2016 to 30 Jun 2017Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017
1 Jul 2015 to 30 Jun 2016Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016
1 Jul 2014 to 30 Jun 2015Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015
1 Jul 2013 to 30 Jun 2014Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014
1 Jul 2012 to 30 Jun 2013Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013
1 Jul 2011 to 30 Jun 2012Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012